Cardiopulmonary Bypass Equipment
SKU
MRR-757B1C9CB0B8
Region
Global
Publication Date
March 2024
Delivery
Immediate
2023
USD 306.91 million
2030
USD 414.51 million
2024
USD 319.92 million
CAGR
4.38%

Cardiopulmonary Bypass Equipment Market by Product (Autotransfusion Systems, Heart–Lung Machines, Oxygenators), Application (Cardiovascular, Hemodialysis, Respiratory), End-User - Global Forecast 2024-2030

[186 Pages Report] The Cardiopulmonary Bypass Equipment Market size was estimated at USD 306.91 million in 2023 and expected to reach USD 319.92 million in 2024, at a CAGR 4.38% to reach USD 414.51 million by 2030.

Cardiopulmonary Bypass Equipment Market
To learn more about this report, request a free PDF copy

Cardiopulmonary bypass equipment, central to cardiopulmonary bypass (CPB) procedures, encompasses a sophisticated assembly designed to temporarily assume the functions of the heart and lungs during cardiac surgery. This arrangement includes a heart-lung machine, tubing for blood transport, an oxygenator to enrich the blood with oxygen and remove carbon dioxide, and various other components such as heat exchangers, filters, and reservoirs. Its primary aim is to maintain circulatory and respiratory stability, enabling surgeons to operate on a still heart in a bloodless field, thus improving surgical visibility and efficacy. Cardiopulmonary bypass equipment plays a pivotal role in the successful outcome of complex cardiac surgeries by precisely controlling blood flow, temperature, and gas exchange. An increase in the geriatric population with rising incidence of cardiac conditions necessitating surgical intervention contributes to market expansion. However, the high cost of CPB devices and surgery can limit market growth, especially in regions with less advanced healthcare systems. Nevertheless, advancements in minimally invasive surgeries and the integration of artificial intelligence for monitoring and predictive analysis during CPB procedures are expected to be significant growth opportunities within the sector.

Cardiopulmonary Bypass Equipment Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
Product: Burgeoning usage of oxygenators as it enhances overall procedure safety and effectiveness

Autotransfusion systems are designed for collecting, processing, and reinfusion of a patient's blood during and after a surgical procedure. This technique is essential in surgeries where significant blood loss is anticipated, reducing the dependency on donor blood transfusions and thus lowering the risks of bloodborne infections and reactions. Autotransfusion systems have evolved to minimize patient exposure to donor blood, addressing major safety concerns. Heart–lung machines are critical for cardiac surgeries, providing circulatory and respiratory support by oxygenating and circulating blood outside the patient's body. This machine is indispensable for procedures requiring the temporary cessation of the heart, such as coronary artery bypass grafting (CABG). Heart–lung machines continue to see innovations to enhance control and patient outcomes, particularly with the integration of AI technologies. Oxygenators play a crucial role in cardiopulmonary bypass equipment, taking over the function of gas exchange from the lungs during cardiac surgeries. They are essential in ensuring the blood remains oxygenated while the patient's lungs are not in use. Oxygenators are being developed with better gas exchange capabilities and minimized complications, enhancing overall procedure safety and effectiveness.

End-User: High usage of cardiopulmonary bypass equipment by dialysis centers

Dialysis centers primarily focus on treatments that require temporary blood filtration, making simple, efficient, and reliable machines a priority. The need here is for equipment that supports the specific requirements of renal dialysis, often integrating features that facilitate easy monitoring and management of fluid balance and electrolyte levels. Hospitals form the most extensive consumer base for cardiopulmonary bypass equipment, given their broad range of surgical procedures that require blood circulation support, such as cardiac surgeries. Hospitals need versatile, high-capacity machines capable of supporting various methods with different complexity levels. Equipment should also be compatible with hospital information systems for seamless integration. Specialty clinics, including those focusing on cardiac care, represent an emerging market for cardiopulmonary bypass equipment. These clinics generally deal with non-emergency surgeries and treatments, necessitating compact, easy-to-use, and cost-effective equipment. The focus is on devices catering to specific surgical needs or patient populations.

Regional Insights

The American market for cardiopulmonary bypass equipment is showing robust growth, driven by technological advancements and increasing cardiac surgeries in the region. The United States leads this market due to its advanced healthcare infrastructure, high healthcare expenditure, and strong presence of key market players. Moreover, increasing awareness about cardiovascular diseases and their treatment options further fuels market growth. Europe is a significant market for cardiopulmonary bypass equipment, supported by its well-established healthcare system and the growing prevalence of cardiovascular diseases among its population. Countries in Europe are investing largely in research and development to innovate bypass machines that offer better outcomes and reduce surgery durations. Middle East and Africa exhibit a growing demand for cardiopulmonary bypass equipment, although at a slower pace than other areas. In the Middle East and Africa, the market growth is primarily driven by the gradual enhancement of healthcare facilities and increasing access to healthcare. The region sees international collaborations and investments, particularly in the Gulf countries, to bolster healthcare infrastructure. The APAC region is emerging as a dynamically growing market for cardiopulmonary bypass equipment. Factors including increasing healthcare expenditure, the growing prevalence of cardiovascular diseases, and improving healthcare infrastructure, particularly in countries like China and India, propel the market growth. Additionally, the rising focus on healthcare reforms and favorable government initiatives are enhancing market prospects in this region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cardiopulmonary Bypass Equipment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cardiopulmonary Bypass Equipment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments
  • Inspira To Unveil New Line of Cardio-Pulmonary Bypass Devices

    Inspira Technologies announced the launch of its Inspira ART series of medical devices, which is set to debut at the upcoming Extracorporeal Life Support Organization (ELSO) Conference in Seattle. The innovative lineup features the ART100, a groundbreaking cardiopulmonary bypass (CPB) device designed to support patients undergoing CPB procedures. Moreover, the company is setting a high bar with its ART500 device, poised to revolutionize the treatment for individuals suffering from severe respiratory distress by offering acute respiratory support that could negate the need for traditional mechanical ventilation. [Published On: 2023-09-28]

  • Inspira Technologies is Developing the VORTX Blood Oxygenator, a Unique Technology for Saturating Blood With Oxygen and Removing Carbon Dioxide

    Inspira Technologies OXY B.H.N. Ltd. unveiled its development, the VORTX Blood Oxygenator. This innovative equipment, under development, signifies a significant leap forward in cardiopulmonary bypass technology. Designed to mimic lung function, the VORTX Blood Oxygenator aims to enhance blood oxygenation and carbon dioxide removal more efficiently than current methods. [Published On: 2023-04-11]

  • LivaNova Receives U.S. FDA 510(k) Clearance for Essenz Heart-Lung Machine for Cardiopulmonary Bypass Procedures

    LivaNova PLC announced the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to its Essenz™ Heart-Lung Machine (HLM), marking a pivotal step in the company's expansion into the U.S. market. Developed in close collaboration with over 300 perfusionists globally, the Essenz Perfusion System, including the Essenz HLM and the Essenz Patient Monitor, introduces a nuanced, data-centric approach to perfusion. This system elevates patient care during cardiopulmonary bypass (CPB) procedures by combining advanced sensing technology and an intuitive user interface to enable goal-directed perfusion, thus reducing the risk of complications such as acute kidney injury. [Published On: 2023-03-09]

Key Company Profiles

The report delves into recent significant developments in the Cardiopulmonary Bypass Equipment Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Becton, Dickinson and Company, Beijing ZKSK Technology Co., Ltd., Braile Biomédica, Brightwake Limited, Chalice Medical Ltd., Fresenius Kabi, Getinge AB, Global Blood Resources, LLC, Johnson & Johnson Services, Inc., LivaNova PLC, MAQUET Holding B.V. & Co. KG., MC3 Cardiopulmonary, Medtronic Plc, MicroPort Scientific Corporation, Nipro Corporation, Owgels Group, Precision Medical, Inc., ProCell Surgical Inc., Senko Medical Instrument Manufacturing Co.,Ltd., Sorin Group, Stryker Corporation, Technowood Corporation, Teleflex Incorporated, Terumo Group, Xenios AG, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Cardiopulmonary Bypass Equipment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Autotransfusion Systems
    • Heart–Lung Machines
    • Oxygenators
  • Application
    • Cardiovascular
    • Hemodialysis
    • Respiratory
  • End-User
    • Dialysis Centers
    • Hospitals
    • Specialty Clinics

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Cardiopulmonary Bypass Equipment Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cardiopulmonary Bypass Equipment Market?
  3. What are the technology trends and regulatory frameworks in the Cardiopulmonary Bypass Equipment Market?
  4. What is the market share of the leading vendors in the Cardiopulmonary Bypass Equipment Market?
  5. Which modes and strategic moves are suitable for entering the Cardiopulmonary Bypass Equipment Market?

Table of Contents
  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & Coverage
    3. Years Considered for the Study
    4. Currency & Pricing
    5. Language
    6. Stakeholders
  2. Research Methodology
    1. Define: Research Objective
    2. Determine: Research Design
    3. Prepare: Research Instrument
    4. Collect: Data Source
    5. Analyze: Data Interpretation
    6. Formulate: Data Verification
    7. Publish: Research Report
    8. Repeat: Report Update
  3. Executive Summary
  4. Market Overview
  5. Market Insights
    1. Market Dynamics
      1. Drivers
        1. Rising prevalence of cardiovascular diseases globally
        2. Increasing demand for minimally invasive surgical procedures
        3. Growing healthcare expenditure and government initiatives to improve healthcare infrastructure
      2. Restraints
        1. High cost associated with cardiopulmonary bypass equipment
      3. Opportunities
        1. Integration of artificial intelligence for monitoring and predictive analysis
        2. Ongoing focus on research and development to develop innovative and cost-effective products
      4. Challenges
        1. Stringent regulatory requirements for product approval
    2. Market Segmentation Analysis
      1. Product: Burgeoning usage of oxygenators as it enhances overall procedure safety and effectiveness
      2. End-User: High usage of cardiopulmonary bypass equipment by dialysis centers
    3. Market Trend Analysis
    4. Cumulative Impact of High Inflation
    5. Porter’s Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    6. Value Chain & Critical Path Analysis
    7. Regulatory Framework
  6. Cardiopulmonary Bypass Equipment Market, by Product
    1. Introduction
    2. Autotransfusion Systems
    3. Heart–Lung Machines
    4. Oxygenators
  7. Cardiopulmonary Bypass Equipment Market, by Application
    1. Introduction
    2. Cardiovascular
    3. Hemodialysis
    4. Respiratory
  8. Cardiopulmonary Bypass Equipment Market, by End-User
    1. Introduction
    2. Dialysis Centers
    3. Hospitals
    4. Specialty Clinics
  9. Americas Cardiopulmonary Bypass Equipment Market
    1. Introduction
    2. Argentina
    3. Brazil
    4. Canada
    5. Mexico
    6. United States
  10. Asia-Pacific Cardiopulmonary Bypass Equipment Market
    1. Introduction
    2. Australia
    3. China
    4. India
    5. Indonesia
    6. Japan
    7. Malaysia
    8. Philippines
    9. Singapore
    10. South Korea
    11. Taiwan
    12. Thailand
    13. Vietnam
  11. Europe, Middle East & Africa Cardiopulmonary Bypass Equipment Market
    1. Introduction
    2. Denmark
    3. Egypt
    4. Finland
    5. France
    6. Germany
    7. Israel
    8. Italy
    9. Netherlands
    10. Nigeria
    11. Norway
    12. Poland
    13. Qatar
    14. Russia
    15. Saudi Arabia
    16. South Africa
    17. Spain
    18. Sweden
    19. Switzerland
    20. Turkey
    21. United Arab Emirates
    22. United Kingdom
  12. Competitive Landscape
    1. Market Share Analysis, 2023
    2. FPNV Positioning Matrix, 2023
    3. Competitive Scenario Analysis
      1. Inspira To Unveil New Line of Cardio-Pulmonary Bypass Devices
      2. Inspira Technologies is Developing the VORTX Blood Oxygenator, a Unique Technology for Saturating Blood With Oxygen and Removing Carbon Dioxide
      3. LivaNova Receives U.S. FDA 510(k) Clearance for Essenz Heart-Lung Machine for Cardiopulmonary Bypass Procedures
  13. Competitive Portfolio
    1. Key Company Profiles
    2. Key Product Portfolio
  14. List of Figures [Total: 22]
    1. CARDIOPULMONARY BYPASS EQUIPMENT MARKET RESEARCH PROCESS
    2. CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, 2023 VS 2030
    3. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, 2018-2030 (USD MILLION)
    4. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
    5. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
    6. CARDIOPULMONARY BYPASS EQUIPMENT MARKET DYNAMICS
    7. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
    8. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
    9. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
    10. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
    11. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
    12. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
    13. AMERICAS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    14. AMERICAS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    15. UNITED STATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
    16. UNITED STATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
    17. ASIA-PACIFIC CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    18. ASIA-PACIFIC CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    19. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    20. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    21. CARDIOPULMONARY BYPASS EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2023
    22. CARDIOPULMONARY BYPASS EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2023
  15. List of Tables [Total: 286]
    1. CARDIOPULMONARY BYPASS EQUIPMENT MARKET SEGMENTATION & COVERAGE
    2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
    3. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, 2018-2023 (USD MILLION)
    4. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, 2024-2030 (USD MILLION)
    5. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
    6. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
    7. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    8. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    9. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY AUTOTRANSFUSION SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
    10. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY AUTOTRANSFUSION SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
    11. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY HEART–LUNG MACHINES, BY REGION, 2018-2023 (USD MILLION)
    12. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY HEART–LUNG MACHINES, BY REGION, 2024-2030 (USD MILLION)
    13. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY OXYGENATORS, BY REGION, 2018-2023 (USD MILLION)
    14. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY OXYGENATORS, BY REGION, 2024-2030 (USD MILLION)
    15. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    16. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    17. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2023 (USD MILLION)
    18. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2024-2030 (USD MILLION)
    19. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2018-2023 (USD MILLION)
    20. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2024-2030 (USD MILLION)
    21. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2023 (USD MILLION)
    22. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY RESPIRATORY, BY REGION, 2024-2030 (USD MILLION)
    23. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    24. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    25. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2018-2023 (USD MILLION)
    26. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2024-2030 (USD MILLION)
    27. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
    28. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
    29. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
    30. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
    31. AMERICAS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    32. AMERICAS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    33. AMERICAS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    34. AMERICAS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    35. AMERICAS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    36. AMERICAS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    37. AMERICAS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    38. AMERICAS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    39. ARGENTINA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    40. ARGENTINA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    41. ARGENTINA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    42. ARGENTINA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    43. ARGENTINA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    44. ARGENTINA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    45. BRAZIL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    46. BRAZIL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    47. BRAZIL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    48. BRAZIL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    49. BRAZIL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    50. BRAZIL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    51. CANADA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    52. CANADA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    53. CANADA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    54. CANADA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    55. CANADA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    56. CANADA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    57. MEXICO CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    58. MEXICO CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    59. MEXICO CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    60. MEXICO CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    61. MEXICO CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    62. MEXICO CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    63. UNITED STATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    64. UNITED STATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    65. UNITED STATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    66. UNITED STATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    67. UNITED STATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    68. UNITED STATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    69. UNITED STATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
    70. UNITED STATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
    71. ASIA-PACIFIC CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    72. ASIA-PACIFIC CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    73. ASIA-PACIFIC CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    74. ASIA-PACIFIC CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    75. ASIA-PACIFIC CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    76. ASIA-PACIFIC CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    77. ASIA-PACIFIC CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    78. ASIA-PACIFIC CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    79. AUSTRALIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    80. AUSTRALIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    81. AUSTRALIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    82. AUSTRALIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    83. AUSTRALIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    84. AUSTRALIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    85. CHINA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    86. CHINA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    87. CHINA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    88. CHINA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    89. CHINA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    90. CHINA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    91. INDIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    92. INDIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    93. INDIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    94. INDIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    95. INDIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    96. INDIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    97. INDONESIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    98. INDONESIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    99. INDONESIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    100. INDONESIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    101. INDONESIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    102. INDONESIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    103. JAPAN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    104. JAPAN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    105. JAPAN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    106. JAPAN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    107. JAPAN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    108. JAPAN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    109. MALAYSIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    110. MALAYSIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    111. MALAYSIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    112. MALAYSIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    113. MALAYSIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    114. MALAYSIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    115. PHILIPPINES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    116. PHILIPPINES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    117. PHILIPPINES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    118. PHILIPPINES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    119. PHILIPPINES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    120. PHILIPPINES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    121. SINGAPORE CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    122. SINGAPORE CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    123. SINGAPORE CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    124. SINGAPORE CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    125. SINGAPORE CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    126. SINGAPORE CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    127. SOUTH KOREA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    128. SOUTH KOREA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    129. SOUTH KOREA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    130. SOUTH KOREA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    131. SOUTH KOREA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    132. SOUTH KOREA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    133. TAIWAN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    134. TAIWAN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    135. TAIWAN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    136. TAIWAN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    137. TAIWAN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    138. TAIWAN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    139. THAILAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    140. THAILAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    141. THAILAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    142. THAILAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    143. THAILAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    144. THAILAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    145. VIETNAM CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    146. VIETNAM CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    147. VIETNAM CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    148. VIETNAM CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    149. VIETNAM CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    150. VIETNAM CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    151. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    152. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    153. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    154. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    155. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    156. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    157. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    158. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    159. DENMARK CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    160. DENMARK CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    161. DENMARK CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    162. DENMARK CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    163. DENMARK CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    164. DENMARK CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    165. EGYPT CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    166. EGYPT CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    167. EGYPT CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    168. EGYPT CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    169. EGYPT CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    170. EGYPT CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    171. FINLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    172. FINLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    173. FINLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    174. FINLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    175. FINLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    176. FINLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    177. FRANCE CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    178. FRANCE CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    179. FRANCE CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    180. FRANCE CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    181. FRANCE CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    182. FRANCE CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    183. GERMANY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    184. GERMANY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    185. GERMANY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    186. GERMANY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    187. GERMANY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    188. GERMANY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    189. ISRAEL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    190. ISRAEL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    191. ISRAEL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    192. ISRAEL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    193. ISRAEL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    194. ISRAEL CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    195. ITALY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    196. ITALY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    197. ITALY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    198. ITALY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    199. ITALY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    200. ITALY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    201. NETHERLANDS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    202. NETHERLANDS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    203. NETHERLANDS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    204. NETHERLANDS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    205. NETHERLANDS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    206. NETHERLANDS CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    207. NIGERIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    208. NIGERIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    209. NIGERIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    210. NIGERIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    211. NIGERIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    212. NIGERIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    213. NORWAY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    214. NORWAY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    215. NORWAY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    216. NORWAY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    217. NORWAY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    218. NORWAY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    219. POLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    220. POLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    221. POLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    222. POLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    223. POLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    224. POLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    225. QATAR CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    226. QATAR CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    227. QATAR CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    228. QATAR CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    229. QATAR CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    230. QATAR CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    231. RUSSIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    232. RUSSIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    233. RUSSIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    234. RUSSIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    235. RUSSIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    236. RUSSIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    237. SAUDI ARABIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    238. SAUDI ARABIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    239. SAUDI ARABIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    240. SAUDI ARABIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    241. SAUDI ARABIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    242. SAUDI ARABIA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    243. SOUTH AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    244. SOUTH AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    245. SOUTH AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    246. SOUTH AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    247. SOUTH AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    248. SOUTH AFRICA CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    249. SPAIN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    250. SPAIN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    251. SPAIN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    252. SPAIN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    253. SPAIN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    254. SPAIN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    255. SWEDEN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    256. SWEDEN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    257. SWEDEN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    258. SWEDEN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    259. SWEDEN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    260. SWEDEN CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    261. SWITZERLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    262. SWITZERLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    263. SWITZERLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    264. SWITZERLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    265. SWITZERLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    266. SWITZERLAND CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    267. TURKEY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    268. TURKEY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    269. TURKEY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    270. TURKEY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    271. TURKEY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    272. TURKEY CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    273. UNITED ARAB EMIRATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    274. UNITED ARAB EMIRATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    275. UNITED ARAB EMIRATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    276. UNITED ARAB EMIRATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    277. UNITED ARAB EMIRATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    278. UNITED ARAB EMIRATES CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    279. UNITED KINGDOM CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    280. UNITED KINGDOM CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    281. UNITED KINGDOM CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    282. UNITED KINGDOM CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    283. UNITED KINGDOM CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    284. UNITED KINGDOM CARDIOPULMONARY BYPASS EQUIPMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    285. CARDIOPULMONARY BYPASS EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2023
    286. CARDIOPULMONARY BYPASS EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2023
  16. List of Companies Mentioned [Total: 27]
    1. Abbott Laboratories
    2. Becton, Dickinson and Company
    3. Beijing ZKSK Technology Co., Ltd.
    4. Braile Biomédica
    5. Brightwake Limited
    6. Chalice Medical Ltd.
    7. Fresenius Kabi
    8. Getinge AB
    9. Global Blood Resources, LLC
    10. Johnson & Johnson Services, Inc.
    11. LivaNova PLC
    12. MAQUET Holding B.V. & Co. KG.
    13. MC3 Cardiopulmonary
    14. Medtronic Plc
    15. MicroPort Scientific Corporation
    16. Nipro Corporation
    17. Owgels Group
    18. Precision Medical, Inc.
    19. ProCell Surgical Inc.
    20. Senko Medical Instrument Manufacturing Co.,Ltd.
    21. Sorin Group
    22. Stryker Corporation
    23. Technowood Corporation
    24. Teleflex Incorporated
    25. Terumo Group
    26. Xenios AG
    27. Zimmer Biomet Holdings, Inc.
Frequently Asked Questions
  1. How big is the Cardiopulmonary Bypass Equipment Market?
    Ans. The Global Cardiopulmonary Bypass Equipment Market size was estimated at USD 306.91 million in 2023 and expected to reach USD 319.92 million in 2024.
  2. What is the Cardiopulmonary Bypass Equipment Market growth?
    Ans. The Global Cardiopulmonary Bypass Equipment Market to grow USD 414.51 million by 2030, at a CAGR of 4.38%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.
DOWNLOAD A FREE PDF
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.